ARG Optimizes Clinical Studies with Veeva Vault eTMF & Veeva Vault CTMS
ARG and Veeva recently collaborated on a case study that focuses on improving trial execution and visibility with Veeva Vault eTMF and Veeva Vault CTMS.Key…
ARG and Veeva recently collaborated on a case study that focuses on improving trial execution and visibility with Veeva Vault eTMF and Veeva Vault CTMS.Key…
Challenge: A pivotal Phase III clinical trial of C1 inhibitor for the prophylactic treatment of hereditary angioedema managed by ARG successfully underwent 3 investigative site…
Challenge: In an economic downturn, small biotech companies often depend on clinical milestones in order to maximize shareholder value and drive market direction. This means…
Challenge: A leading specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases was mired in an…
Challenge: A specialty biopharmaceutical company targeting the therapeutic power of plasma for the treatment of chronic, life-altering diseases like hemophilia and immune deficiencies, contracted with…